Machine Learning Rafael and Curesponse to Collaborate on Precision Oncology Platform AIT News Desk Feb 4, 2022 Curesponse and Rafael to collaborate on integrating Artificial Intelligence capabilities in precision oncology platform. This collaboration…
Diagnosis Curesponse Secures $6 Million Series a for Breakthrough Precision Medicine AIT News Desk Jun 5, 2020 Curesponse Is a Cancer Precision Medicine Company Whose Platform, Cresponse, Accurately and Quickly Predicts a Patient's Response to Cancer Treatment.…